Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boehringer Mannheim

This article was originally published in The Gray Sheet

Executive Summary

David Giddings named president of Boehringer Mannheim Corporation and Staffan Ek appointed president of the diabetes care business. Giddings will continue in his position as chief operating officer and will now "assume responsibility for the corporate affairs" of the Corange division. Before arriving at BMC in 1992, Giddings served as vice president and general manager of Eastman Kodak's printing and publishing division and clinical diagnostics division. Ek most recently served as head of international sales and marketing for the diabetes care unit, joining the company in 1992 after 20 years at Pharmacia. Giddings and Ek replace Andre de Bruin, who served as both president and CEO of Boehringer and president of Diabetes Care. de Bruin resigned July 1 to "pursue new business opportunities in the health care field"

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002571

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel